This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
deSauvage, F. J. et al. Nature 369, 533–538 (1994).
Lok, S. et al. Nature 369, 565–568 (1994).
Kaushansky, K. et al. Nature 369, 568–571 (1994).
Wendling, F. et al. Nature 369, 571–574 (1994).
McDonald, T. P. Exp. Hematol. 16, 201–205 (1988).
Souyri, M. et al. Cell 63, 1137–1147 (1990).
Methia, N., Louache, F., Vainchenker, W. & Wendling, F. Blood 82, 1395–1401 (1993).
Dührsen, U., Stahl, J. & Gough, N. M. EMBO J. 9, 1087–1096 (1990).
Metcalf, D. & Rasko, J. E. J. Leukemia 7, 878–886 (1993).
Sheridan, W. P. et al. Lancet 339, 640–644 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Metcalf, D. Thrombopoietin — at last. Nature 369, 519–520 (1994). https://doi.org/10.1038/369519a0
Issue Date:
DOI: https://doi.org/10.1038/369519a0
This article is cited by
-
Failing to Live Up to the Fanfare? A Personal Perspective on Obstacles to the Clinical Development of Thrombopoietic Agents
International Journal of Hematology (2001)
-
Platelet stimulating agents — off the launching pad
Nature Medicine (1997)